CPHI 2026 – 23/07/2026
PCI Drug-Device 28/05/2026

Current Edition

ramusmedical
Europe

Viracta Initiates Treatment of First Patient in EBV+ Lymphoma Clinical Trial with Tractinostat

Viracta Therapeutics, a clinical-stage drug development company advancing innovative approaches to treat viral-associated cancers and other serious diseases, has init...
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026